[6] Tenorio R.P., Carvalho C.S., Pessanha C.S., de Lima J.G., de Faria A.R., Alves A.J., de Melo E.J.T.,
Goes A.J.S.,
Synthesis of Thiosemicarbazone and 4-Thiazolidinone Derivatives and Their in Vitro anti-Toxoplasma gondii Activity, Bioorg. Med. Chem. Lett., 15: 2575-2578 (2005).
[18] Andres C.J., Bronson J.J., D’Andrea S.V., Deshpande M.S., Falk P.J., Grant-Young K.A., Harte W.E., Ho H.–T., Misco P.F., Robertson J.G., Stock D., Sun Y., Walsh A.W., 4-
Thiazolidinones: Novel Inhibitors of the Bacterial Enzyme MurB, Bioorg. Med. Chem. Lett., 10: 715-717 (2000).
[20] Hu J., Wang Y., Wei X., Wu X., Chen G., Cao G., Shen X., Zhang X., Tang Q., Liang G., Li X.,
Synthesis and Biological Evaluation of Novel Thiazolidinone Derivatives as Potential Anti-Inflammatory Agents, Eur. J. Med. Chem., 64: 292-301 (2013).
[21] Schenone S., Bruno O., Ranise A., Bondavalli F., Filippelli W., Falcone G., Giordano L., Vitelli M.R.,
3-Arylsulphonyl-5-arylamino-1,3,4-thiadiazol-2(3H)ones as Anti-Inflammatory and Analgesic Agents, Bioorg. Med. Chem., 9: 2149-2153 (2001).
[22] Barreca M.L., Chimirri A., Luca L.D., Monforte A.–M., Monforte P., Rao A., Zappala M., Balzarini J.,
De Clercq E., Pannecouque C., Witvrouw, M.,
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as Potent Anti-HIV-1 Agents,
Bioorg. Med. Chem. Lett.,11: 1793-1796 (2001).
[27] Reddy K.A., Lohray B.B., Bhushan V., Bajji A.C., Reddy K.V., Reddy P.R., Hari Krishna T., Rao I.N., Jajoo H.K., Mamidi Rao N.V.S., Chakrabarti R., Kumar T.D., Rajagopalan R.,
Novel Antidiabetic and Hypolipidemic Agents. 3. Benzofuran-Containing Thiazolidinediones,
J. Med. Chem., 42: 1927-1940 (1999).
[29] Cunico W., Gomes C.R.B., Ferreira M.L.G., Capri L.R., Soares M., Wardell S.M.S.V.,
One-Pot Synthesis of 2-isopropyl-3-benzyl-1,3-thiazolidin-4-ones and 2-phenyl-3-isobutyl-1,3-thiazolidin-4-ones From Valine, Arenealdehydes and Mercaptoacetic Acid, Tetrahedron Lett., 48:6217-6220 (2007).
[35] Holmes C.P., 1996 WO 96/ 00148.
[38] Reddy N.T., Ravinder M., Bagul P., Ravikanti K., Bagul C., Nanubolu J.B., Srinivas K., Banarjee S.K., Jayathirtha Rao V.,
Synthesis and Biological Evaluation of New Epalrestat Analogues as Aldose Reductase Inhibitors (ARIs), Eur. J. Med. Chem., 71: 53-66 (2014).
[39] Gangadasu B., Narender P., Bharath Kumar S., Ravinder M., Ananda Rao B., Ramesh Ch., China Raju B., Jayathirtha Rao V.,
Facile and Selective Synthesis of Chloronicotinaldehydes by the Vilsmeier Reaction, Tetrahedron, 62: 8398-8403 (2006).
[41] NCCL-National Committee for Clinical Laboratory Standards (NCCLS). Standard Methods for Dilution Antimicrobial susceptibility tests for Bacteria Which Grow Aerobically. Nat. Comm., Clin Lab Stands Villanova, (1982).